Security key
65343E108
NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)
CUSIP: 65343E108
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 10,545,575
- Total 13F value
- $5,647,089
- Share change
- -4,820,037
- SEC-reported price per share
- $0.46
- Number of holders
- 29
- Value change
- -$11,042,788
- Number of buys
- 7
- Number of sells
- 20
- Shares outstanding
- 3,602,511
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
29
Top holders
10
NXTC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NextCure, Inc. SEC filings
NextCure, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 65343E108
Recent filing periods:
Ownership snapshot
Top reported holders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Simcere Zaiming, Inc.
Disclosed value leader
Simcere Zaiming, Inc.
Comparable rows
15/15
Latest evidence
20 Jun 2025
13D/G
3/4/5
13F
Lead comparable stake: 13%
13D/G row: Simcere Zaiming, Inc.
Showing 1-6 of 15 holder rows.
Quick read
Simcere Zaiming, Inc. leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Simcere Zaiming, Inc.'s linked filing trail.
Comparable ownership
Top 5
Simcere Zaiming, Inc.
13%
CITIGROUP INC
4.3%
Sofinnova Investments, Inc.
74%
Affinity Asset Advisors, LLC
64%
PFIZER INC
53%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Simcere Zaiming, Inc. |
13D/G
3/4/5
10%+ Owner
|
13%
|
$1,696,566
338,636 shares
|
$0 | 20 Jun 2025 |
| CITIGROUP INC |
13F
13D/G
Company · Citigroup Global Markets Inc.
|
4.3%
from 13D/G
|
$681,723
1,419,370 shares
|
— | 31 Mar 2025 |
| Sofinnova Investments, Inc. |
13F
Company
|
74%
|
$1,283,292
2,671,856 shares
|
— | 31 Mar 2025 |
| Affinity Asset Advisors, LLC |
13F
Company
|
64%
|
$1,105,938
2,302,598 shares
|
— | 31 Mar 2025 |
| PFIZER INC |
13F
Company
|
53%
|
$908,614
1,891,763 shares
|
— | 31 Mar 2025 |
| ORBIMED ADVISORS LLC |
13F
Company
|
32%
|
$548,118
1,141,200 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
29
Shares
10,545,575
Rows available
29
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2025 holders
29
Holder diff
28
| Investor | Q3 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend